Systemic fungal infections occur in an estimated 2% to 5% of very low birth weight (VLBW) infants, thus remaining a significant factor for morbidity and mortality in this population. 1 Although Candida albicans is the most commonly identified species, fungal infections from Aspergillus, Trichosporon and Curvularia have been reported. 2 We present a premature infant with disseminated fungal infection that resulted from Bipolaris spicifera. This organism is emerging as a more commonly seen pathogen in immunocompromised adults. However, careful review of the literature on Medline 1966 through February 2000 yielded no prior reports of this organism as a pathogen in preterm infants. A report of this case with dermatologic considerations was printed in Cutis (March 2000). 3 
CASE REPORT
Baby L was a female infant born vaginally at 23 4/7 weeks' gestation, weighing 780 g. Her delivery was precipitated by a subacute placental abruption secondary to a motor vehicle accident 8 days prior. The infant was intubated and given surfactant immediately after delivery and placed on highfrequency ventilation (HFOV). Pulmonary management was augmented with low-dose dexamethasone (0.1 mg/kg per day) on day of life (DOL) 2 to 7. The patient was initially started on total parenteral nutrition with intralipids added on DOL 4. Other interventions during the first week of life included 3 days of ampicillin and cefotaxime while bacterial sepsis was ruled out, hyperglycemia requiring control with insulin, and hyperbilirubinemia treated with spotlight phototherapy and fiberoptic phototherapy blanket. Skin care for the infant included sterilized sheep wool bedding, the use of Aquaphor and a humidified air tent.
By DOL 7 the patient's respiratory status had improved and she was changed from HFOV to conventional ventilation. It was noted, however, that erythematous lesions on her neck, back, and buttocks had appeared along with superficial skin breakdown in these areas. Despite the skin care provided and repositioning, the lesions progressed to black lesions eroding down to the fascial layers of underlying muscle (Figure 1) . A shave biopsy showed invasive fungal organisms extending deep into the subcutaneous tissue to the surgical margin ( Figure 2 ). The invasive hyphae had bubbly cytoplasm, thick refractile walls, and focal pigmentation consistent with phaeohyphomycosis. Culture of the biopsy tissue yielded the organism B. spicifera. Therapy with liposomal amphotericin (Abelcet) at 5 mg/kg per day and itraconazole at 7.5 mg/kg per day was started. Peak and trough itraconazole levels were obtained around the sixth dose with levels of 7.4 and 6.5 g/ml, respectively. The infant underwent extensive surgical debridement of the focal lesions, the largest of which (on the left gluteal region) measured 4.5Â1.9 cm.
On DOL 14 new black necrotic skin lesions similar to the initial lesions were noted on the right thigh, buttocks, arms, and right third toe despite antifungal therapy. The new lesions were small and distinct from the original skin ulcerations. A second surgical debridement was performed on the new skin lesions in addition to the wound edges from the previous debridements. During the second week of life the patient's condition deteriorated with coagulase negative staphylococcus
We report a premature infant with disseminated fungal infection identified as Bipolaris spicifera. The infant was born at 23 4 / 7 weeks' gestation, weighing 780 g. At day of life ( DOL ) 7 erythematous areas on the back were noticed that progressed to black, necrotic skin lesions. A shave biopsy showed invasive fungal organisms that were identified by culture as B. spicifera. The lesions progressed despite aggressive surgical debridement and antifungal therapy. On autopsy, fungal organisms found throughout the internal organs confirmed disseminated disease with B. spicifera. This organism is now more often recognized as a human pathogen; however, this is the first reported case in a neonate. 
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bacteremia, hypotension requiring pressor support, Grade 2 bilateral intraventricular hemorrhages, and worsening pulmonary status. Although multiple cultures, heart, and eye exam did not identify fungus, a renal ultrasound displayed hypoechoic areas of both kidneys consistent with fungal disease. The patient continued to deteriorate and expired on DOL 19. The pathologic evaluation revealed the cause of death to be multiorgan failure associated with extreme prematurity complicated by disseminated fungal disease. Postmortem examination was remarkable for necrotizing granulomatous inflammation associated with fungal organisms involving the lungs, heart, thyroid, kidneys, adrenals, and brain. The disseminated fungus had similar morphology to the organism seen in the biopsy of the ulcerated skin lesions (Figure 3 ). Fungal periodic acid-Schiff (PAS) and Gomori's methenamine-silver stains were used to enhance visualization of the fungal organisms present in the brain, meninges, heart, lungs, and liver ( Figure 4 ). All biopsies displayed uniform hyphae with parallel walls and distinct septations. The autopsy findings confirmed the infant was infected with disseminated B. spicifera. 
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Disseminated Bipolaris Spicifera in an Neonate DISCUSSION B. spicifera has been a relatively unknown agent to the majority of clinicians but now is being recognized with increasing frequency as a cause of human disease, in particular sinusitis. 4, 5 Skin lesions usually appear as abscesses, frequently with a surrounding capsule; however, in immunocompromised patients the lesion may appear erythematous with induration initially. 4 Although dissemination of B. spicifera is usually seen in immunocompromised hosts, there has been a case report of central nervous system disease occurring in an immunocompetent child. 6 The increasing number of cases of disseminated disease reported in recent years parallels the rise in the number of immunocompromised patients especially those with AIDS and transplant recipients. 7 Also, as use of broad spectrum antibiotics continues, the risk of toxicity and emergence of fungal and resistant bacterial organisms increases. Apparent additional risk factors important in the acquisition and dissemination of dematiaceous fungi in the VLBW infant include incompetent integument, intralipids and steroids in this population.
Therapy for cutaneous lesions involves aggressive surgical debridement with infection free margins. Secondary treatment and treatment for disseminated disease relies on antifungal drug therapy; however, many of the formulations are ineffective against this organism in clinical practice. Amphotericin B has traditionally been used in addition to ketoconazole, miconazole, and 5-fluorocytosine. 4 In recent years, as a result of treatment outcomes in the adult population, itraconazole has been recognized as the treatment of choice for dematiaceous fungi. This organism was susceptible in vitro to amphotericin with a minimum inhibitory concentration (MIC) of 0.25 g/ml at 72 hours. It was also susceptible to itraconazole in vitro with a MIC of 0.03 g/ml at 72 hours. These concentrations are consistent with published in vitro MIC for B. spicifera of 0.25 to 1.0 g/ml for amphotericin and 0.015 to 0.125 g/ml for itraconazole. 8 However, this does not necessarily correlate with clinical cure of disease as has been previously recognized in cases of disease with similar organisms. 4 There is now interest in combination therapy for treatment of these organisms; however, outcomes of combination therapy have not been reported in the literature.
The premature infant is one subset of the pediatric population with compromised immune function, yet until this infant there have been no reports of disseminated B. spicifera in this group. A few important observations can be made from this case. First, although serum levels of itraconazole exceeded the MIC for the organism and she received standard doses of amphotericin B, there was progression of disease. This implies that in vitro sensitivities do not necessarily predict a favorable in vivo response. Another observation is that there was a recurrence of disease at the site of a previously debrided lesion where infection-free margins were not obtained. In VLBW infants debridement of fungal lesions presents a difficult problem. If clear margins are not obtained the disease can progress. However, if debridement is too aggressive the child will be at increased risk of fluid imbalance and bacterial infection. Finally, the fact that multiple distinct skin lesions appeared over time increased the suspicion that the fungus had widely disseminated, prompting further diagnostic workup confirming the dissemination.
Fungal organisms are ubiquitous and not always associated with any obvious source of infection, as with this patient. It is important to remember that when caring for VLBW infants with unusual skin lesions, fungal infections including B. spicifera must be in the differential. Early skin biopsy followed by prompt aggressive surgical debridement may eradicate the organism before local or systemic spread occurs. Once the fungus has either spread locally, making adequate surgical debridement difficult, or has disseminated, it appears that antifungal medication may not be curative in the VLBW population. As the age of viability continues to decline in the neonatal population, increased recognition of emerging fungal infections and their prompt treatment will become increasingly important.
